EC chi hơn 70 triệu USD mua thuốc remdesivir điều trị COVID-19
Nhằm đáp ứng nhu cầu cấp bách hiện nay cho các bệnh nhân mắc dịch viêm đường hô hấp cấp COVID-19 ở châu Âu, ngày 29/7, Ủy ban châu Âu (EC) thông báo đã đồng ý mua thuốc kháng virus remdesivir vốn khan hiếm của công ty dược phẩm Mỹ Gilead Sciences.
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
(TTXVN/Vietnam+)